» Articles » PMID: 996922

Preparation of Cryoprecipitated Factor VIII Concentrates

Overview
Journal Transfusion
Specialty Hematology
Date 1976 Nov 1
PMID 996922
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Factors affecting the yield of factor VIII in cryoprecipitate have been investigated in the context of a blood component program. Both in vitro and in vivo measurements were used to assess the effects of critical variables on the yield of factor VIII activity. Variables such as anticoagulant, plastic bag, mixing during collection, and platelet contamination had no significant effect on yield of factor VIII activity in cryoprecipitate. Among the most critical factors affecting yield were storage time of whole blood and procedures for freezing, thawing, and reconstitution. The following procedures were found to assure a 60 per cent recovery of factor VIII in cryoprecipitate: 1)processing of whole blood within six hours of collection; 2)use of a technique to freeze plasma within 30 minutes either in a -70 C ethanol bath or -85 C freezer; 3)rapid thawing (1 1/2 hour or less) in a 4 C circulating water bath; 4)centrifugation at 4,500 X g for 10 minutes at 4 C followed by draining of the supernatant in a 4 C cold room; 5) storage of the precipitate at -20 C until ready for use; 6) thawing in a 37 C water bath for at least 15 minutes followed by addition of 20 ml of 0.15 M saline for a 20 minute period at room temperature, and gentle mixing before pooling units for transfusion. The recovery of factor VIII in cryoprecipitate appears to be limited to about 65 per cent by its solubility in plasma at 4 C. Therefore, further effort to increase the amount available for treatment should involve improving the supply of plasma for its preparation and decreasing the cost of processing.

Citing Articles

Use of Cryoprecipitate in Newborn Infants.

Tyagi M, Guaragni B, Dendi A, Tekleab A, Motta M, Maheshwari A Newborn (Clarksville). 2023; 2(1):11-18.

PMID: 37206579 PMC: 10193588. DOI: 10.5005/jp-journals-11002-0045.


Factors affecting the quality of cryoprecipitate.

Subramaniyan R, Marwaha N, Jain A, Ahluwalia J Asian J Transfus Sci. 2017; 11(1):33-39.

PMID: 28316438 PMC: 5345278. DOI: 10.4103/0973-6247.200778.


Studies on the procurement of blood coagulation factor VIII: effects of plasma freezing rate and storage conditions on cryoprecipitate quality.

Farrugia A, Prowse C J Clin Pathol. 1985; 38(4):433-7.

PMID: 3921572 PMC: 499172. DOI: 10.1136/jcp.38.4.433.


Prophylactic platelet administration during massive transfusion. A prospective, randomized, double-blind clinical study.

Reed 2nd R, Ciavarella D, Heimbach D, Baron L, Pavlin E, Counts R Ann Surg. 1986; 203(1):40-8.

PMID: 3510591 PMC: 1251037. DOI: 10.1097/00000658-198601000-00008.


Abuse of fresh frozen plasma.

Jones J Br Med J (Clin Res Ed). 1987; 295(6593):287.

PMID: 3115415 PMC: 1247136. DOI: 10.1136/bmj.295.6593.287.